Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

310 results found

2020 ∙ Alizadeh Chamkhaleh, M. Esteghamati, A. Sayyahfar, S. Gandomi-Mohammadabadi, A. Balasi, J. Abdiaei, H. Moradi, Y. Moradi-Lakeh, M.

Serotype distribution of Streptococcus pneumoniae among healthy carriers and clinical patients: a systematic review from Iran

  • Eastern Mediterranean
  • Islamic Republic of Iran
  • All age groups
  • Pneumococcal disease
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2020 ∙ Kuehne, F. Sanftenberg, L. Dreischulte, T. Gensichen, J.

Shared decision making enhances pneumococcal vaccination rates in adult patients in outpatient care

  • Adults
  • Older adults
  • Pneumococcal disease
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2020 ∙ Silva, S. M. Rodrigues, I. C. G. Santos, R. D. S. Ternes, Y. M. F.

The direct and indirect effects of the pneumococcal conjugated vaccine on carriage rates in children aged younger than 5 years in Latin America and the Caribbean: a systematic review

  • Americas
  • Newborn
  • Children
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2020 ∙ Marra, F. Zhang, A. Gillman, E. Bessai, K. Parhar, K. Vadlamudi, N. K.

The protective effect of pneumococcal vaccination on cardiovascular disease in adults: A systematic review and meta-analysis

  • Adults
  • Older adults
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2020

Advice on the changes to the PCV13 immunization schedule

  • Recommendation
  • Africa
  • Burkina Faso
  • Pneumococcal disease
Download:
2020 ∙ Conseil Supérieur de la Santé (CSS)

Pneumococcal vaccination for adults

  • Recommendation
  • Europe
  • Belgium
  • Pneumococcal disease
Download:
2020 ∙ Haute Autorité de Santé

Pneumococcal vaccination in the context of supply issues and the COVID-19 epidemic in France

  • Recommendation
  • Europe
  • France
  • Pneumococcal disease
Download:
2019 ∙ McGirr, A. Iqbal, S. M. Izurieta, P. Talarico, C. Luijken, J. Redig, J. Newson, R. S.

A systematic literature review and network meta-analysis feasibility study to assess the comparative efficacy and comparative effectiveness of pneumococcal conjugate vaccines

  • Newborn
  • Children
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2019 ∙ Leidner, A. J. Murthy, N. Chesson, H. W. Biggerstaff, M. Stoecker, C. Harris, A. M. Acosta, A. Dooling, K. Bridges, C. B.

Cost-effectiveness of adult vaccinations: A systematic review

  • Americas
  • United States of America
  • Canada
  • Adults
  • Influenza
  • Pneumococcal disease
  • Human papillomavirus (HPV)
  • Herpes zoster
  • Hepatitis B
  • Tetanus
  • Diphtheria
  • Pertussis
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2019 ∙ Sings, H. L. De Wals, P. Gessner, B. D. Isturiz, R. Laferriere, C. McLaughlin, J. M. Pelton, S. Schmitt, H. J. Suaya, J. A. Jodar, L.

Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-analysis of Observational Studies

  • Newborn
  • Children
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
Loading...